Acadia Healthcare (NASDAQ:ACHC) Reaches New 52-Week High on Analyst Upgrade

Key Points

• Acadia Healthcare hit a new 52-week high after Guggenheim raised its price target to $31 and kept a buy rating, with shares trading around $29 and up roughly 3.6% at mid-day.
• The company beat Q1 estimates (EPS $0.37 vs. $0.28 expected; revenue $828.8M vs. $823.5M) and set Q2 guidance of $0.30–$0.40 EPS, while revenue grew about 7.6% year‑over‑year.
• Analyst views are mixed—one Strong Buy, six Buy, seven Hold and two Sell with a consensus target of $25.81—while institutional investors like Goldman Sachs and UBS have recently increased their stakes.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) hit a new 52-week high during mid-day trading on Monday after Guggenheim raised their price target on the stock from $26.00 to $31.00. Guggenheim currently has a buy rating on the stock. Acadia Healthcare traded as high as $28.74 and last traded at $29.0760, with a volume of 17545 shares. The stock had previously closed at $27.85.

A number of other brokerages also recently issued reports on ACHC. UBS Group upped their price target on Acadia Healthcare from $27.00 to $31.00 and gave the company a "buy" rating in a report on Friday, April 17th. Jefferies Financial Group restated a "hold" rating and set a $24.50 price objective on shares of Acadia Healthcare in a research report on Monday, April 20th. Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Raymond James Financial upgraded shares of Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 price target on the stock in a research note on Monday. Finally, Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an "outperform" rating in a research report on Thursday, February 26th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $25.81.

Institutional Trading of Acadia Healthcare

A number of large investors have recently bought and sold shares of ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Acadia Healthcare in the first quarter valued at $1,600,000. Goldman Sachs Group Inc. grew its holdings in shares of Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company's stock worth $21,170,000 after buying an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company's stock valued at $10,337,000 after acquiring an additional 27,207 shares during the period. American Century Companies Inc. raised its stake in Acadia Healthcare by 531.5% during the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company's stock valued at $2,399,000 after acquiring an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. lifted its position in Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company's stock worth $225,000 after acquiring an additional 1,780 shares during the period.

Acadia Healthcare Stock Up 3.6%

The company has a market capitalization of $2.65 billion, a PE ratio of -2.37, a P/E/G ratio of 9.39 and a beta of 0.73. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a 50 day simple moving average of $24.43 and a two-hundred day simple moving average of $19.12.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million during the quarter, compared to analysts' expectations of $823.51 million. During the same quarter in the prior year, the business earned $0.40 earnings per share. The company's quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 1.48 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.